Clinical Trials Directory

Trials / Unknown

UnknownNCT04642677

REcommened Communication With Sympathy in Terminally Ill Cancer Patients Treated With Palliative Sedation

Randomized phasE II Study for Efficacy of healThcare prOvider's REcommened Communication With Sympathy in Terminally Ill Cancer Patients Treated With Palliative Sedation

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Pusan National University Yangsan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

* In terminally ill cancer patients, palliative sedation has been applied to intractable refractory symptoms such as pain, dyspnea, delirium, agitation. * Palliative sedation is generally an adaptive strategies using midazolam, which is composed of intermittent bolus, limited continuous, or 24hr continuous infusion depending on the time of drug application. * In the application of palliative sedation, caregiver's negative feelings such as anxiety or guilt for palliative sufficiency are one of the biggest challenges as the patient's consciousness is reduced, and they feels disconnected from the patient. * In general, hearing is known to persist until the very last moment of the end of life, regardless of consciousness. In addition, maintaining communication with patients and caregivers is the most important part of the hospice. * This study evaluate the efficacy of healthcare provider's recommended communication with sympathy, "Regardless of the patient's outward consciousness, talk with the patient and express empathy. Hearing will be maintained until the end."

Conditions

Interventions

TypeNameDescription
OTHERhealthcare provider's recommended communication with sympathy and printed paperPatients and caregivers were received healthcare provider's recommended communication with sympathy and printed paper, "Regardless of the patient's outward consciousness, talk with the patient and express empathy. Hearing will be maintained until the end." three times a day (8, 14 and 20 o'clock) during palliative sedation.

Timeline

Start date
2020-11-01
Primary completion
2022-11-30
Completion
2022-11-30
First posted
2020-11-24
Last updated
2021-11-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04642677. Inclusion in this directory is not an endorsement.